OPDIVO QVANTIG

nivolumab and hyaluronidase-nvhy · E.R. Squibb & Sons, L.L.C.

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for OPDIVO QVANTIG, covering 2024-12-27 to 2025-11-24. Get the full timeline:

Most recent: FDA Approved: OPDIVO QVANTIG — Supplemental Application (E.R. Squibb & Sons, L.L.C.)